• Received non-binding letter of intent from prominent multinational software business
• Proposed acquisition of MedAdvisor's ANZ business division for cash
• Offer represents materially higher value than current share price

MedAdvisor Limited (ASX: MDR) has received a Non-binding Letter of Intent (LOI) from a prominent multinational listed software business with operations in the Australian market. The LOI outlines a proposal to acquire the Company's ANZ business division for cash considerations. While the proposal remains 'commercial in confidence' at this time, the directors believe it represents a materially higher value than what is implied in the current MedAdvisor share price. On that basis, MedAdvisor has executed the LOI in the best interest of shareholders. The receipt of the LOI is in line with the Company's previously announced review of strategic options, which aimed to consider various initiatives to bridge the valuation gap between the market capitalization and the Board's perceived fair value of its ANZ and US business units. The ANZ business continues to perform strongly, achieving record revenue of A$2.9 million in April 2025. The LOI includes customary conditions such as a period of exclusivity to conduct due diligence, and given the significant preliminary work already undertaken by both parties, the timeframe for execution of a binding sale and purchase agreement is expected to be approximately 5 to 7 weeks.

The Company will update the market in the event a transaction with the counterparty does not proceed.